About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lifestyle Medicine for Depression 2019 | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT04070417

Lifestyle Medicine for Depression 2019

This study will examine the feasibility and efficacy of lifestyle medicine for the enhancement of psychological wellness in adult. The main components of lifestyle intervention typically include physi...

Lead sponsor: Chinese University of Hong Kong•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Chinese University of Hong Kong

Collaborators

University of Melbourne
University of Western Sydney

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Hong Kong residents aged ≥ 18 years;
•Cantonese language fluency;
•Patient Health Questionnaire (PHQ-9) score ≥ 10; and
•Willingness to provide informed consent and comply with the trial protocol

Exclusion Criteria

•Pregnancy;
•Have suicidal ideation with PHQ-9 item 9 score ≥ 2 (referral information to professional services will be provided to those who endorsed items on suicidal ideation);
•Using medication or psychotherapy for depression;
•Having unsafe conditions and are not recommended for physical activity or a change in diet by physicians; and
•Have major psychiatric, medical or neurocognitive disorders that make participation infeasible or interfere with the adherence to the lifestyle intervention

Related studies

The Mom and Infant Outcomes (MOMI) Study

NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600 · Parents, Children With Disabilities, and more

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

RECRUITINGPhase 4

Establishing Mobile Transcranial Magnetic Stimulation

NCT06748209 · Treatment Resistant Major Depression

RECRUITINGPhase 1/2

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

NCT05685368 · Race-related Stress, Depression, Anxiety, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2020Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment30

Start dateNov 2019

Last updatedJan 7, 2020

Condition

Locations shown

The Chinese University of Hong Kong

Hong Kong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions